Goal 3: Advance Translational Research

Advancing the preservation of cellular therapies

Cell therapies are produced in specialized facilities and the viability/function of the cells must be retained in order to permit transportation to the site of use, coordination with patient care, etc. Current options for preserving cells are limited. Conventional methods of cryopreservation may result in poor post thaw function and are difficult to use at the point of care. Liquid storage of cells is typically limited to 24-48 h. A critical challenge is to develop a toolkit of preservation technologies that will maintain viability/function and technology that enables cells to be used at the point of care.

Tags (Keywords associated with the idea)


-12 net votes
11 up votes
23 down votes
Idea No. 361